摘要:
The invention refers to tumor-homing cells expressing the tumor necrosis factor-related apoptosis inducing ligand (TRIAL), particularly to CD34+ and NK cells transduced with adenoviral vectors coding for TRIAL. The cells of the invention are useful for the intravenous treatment of tumors, particularly of lymphoma.
摘要:
Combined pharmaceutical preparation containing G-CSF and PIGF as the active substances, are useful in the mobilization of blood stem cells in a patient or subject in need thereof.